Related Experiment Video
Updated: Apr 26, 2026

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
Published on: September 30, 2014
Bactericidal effect of bovine lactoferrin and synthetic peptide lactoferrin chimera in Streptococcus pneumoniae and
Nidia León-Sicairos1, Uriel A Angulo-Zamudio, Jorge E Vidal
1Unidad de Investigación, Facultad de Medicina, Universidad Autónoma de Sinaloa, Cedros y Sauces, Fracc. Fresnos., C.P. 80246, Culiacán, Sinaloa, Mexico, nidialeon@uas.edu.mx.
Insights
Bovine lactoferrin (bLF) and a chimeric peptide (LFchimera) show bactericidal effects against Streptococcus pneumoniae. These agents also reduce bacterial virulence by down-regulating key genes, offering potential for new pneumococcal infection treatments.
Area of Science:
- Microbiology
- Immunology
- Biochemistry
Background:
- *Streptococcus pneumoniae* (pneumococcus) causes nearly one million child deaths annually from infections like pneumonia and meningitis.
- Lactoferrin (LF) is an antibacterial protein in the human immune system, but its efficacy against pneumococcus requires further study.
Purpose of the Study:
- To evaluate the bactericidal activity of bovine lactoferrin (bLF) and synthetic lactoferrin-derived peptides against *S. pneumoniae*.
- To investigate the mechanism of bacterial damage and the impact on virulence gene expression.
Main Methods:
- Treatment of *S. pneumoniae* planktonic cells with bLF and LF-peptides.
- Assessment of cell viability (CFU/ml), interaction via confocal microscopy and flow cytometry, structural damage via electron microscopy, membrane permeabilization, and gene expression (qRT-PCR).
Main Results:
- bLF and LFchimera demonstrated significant bactericidal effects.
- Interaction with bacteria caused morphological changes and membrane permeabilization.
- LF treatment led to down-regulation of the *luxS* gene, a key virulence factor.
Conclusions:
- bLF and LFchimera exhibit potent bactericidal activity against *S. pneumoniae*.
- LF and LFchimera disrupt bacterial cell structure and membrane integrity.
- LF's ability to down-regulate virulence genes highlights its potential as a novel therapeutic agent for pneumococcal infections.
Abstract:
Streptococcus pneumoniae (pneumococcus) is responsible for nearly one million child deaths annually. Pneumococcus causes infections such as pneumonia, otitis media, meningitis, and sepsis. The human immune system includes antibacterial peptides and proteins such as lactoferrin (LF), but its activity against pneumococcus is not fully understood. The aim of this work was to evaluate the bactericidal effect of bovine lactoferrin (bLF) and the synthetic LF-peptides lactoferricin (LFcin17-30), lactoferrampin (LFampin265-284), and LFchimera against S. pneumoniae planktonic cells. The mechanism of damage was also investigated, as well as the impact of these peptides on the transcription levels of genes known to encode important virulence factors. S. pneumoniae planktonic cells were treated with bLF, LFcin17-30, LFampin265-284 and LFchimera at different time points. The viability of treated planktonic cells was assessed by dilution and plating (in CFU/ml). The interaction between LF and LF-peptides coupled to fluorescein was visualized using a confocal microscope and flow cytometry, whereas the damage at structural levels was observed by electron microscopy. Damage to bacterial membranes was further evaluated by membrane permeabilization by use of propidium iodide and flow cytometry, and finally, the expression of pneumococcal genes was evaluated by qRT-PCR. bLF and LFchimera were the best bactericidal agents. bLF and peptides interacted with bacteria causing changes in the shape and size of the cell and membrane permeabilization. Moreover, the luxS gene was down-regulated in bacteria treated with LF. In conclusion, LF and LFchimera have a bactericidal effect, and LF down-regulates genes involved in the pathogenicity of pneumococcus, thus demonstrating potential as new agents for the treatment of pneumococcal infections.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
10:13Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
Published on: August 11, 2018
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Clinical Significance of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Inhibitors of Bacterial Protein Synthesis
Mechanism of Antibiotic Resistance in MRSA